Clinial study of shengxue mixture(生血合剂)in treating aplastic anemia

摘要

The basic cure was gained in 18 cases, remission in 23, markedly improved in 32, ineffective 11, total effective rate and cure remission rate of the treated group were 86.90/100 and 48.81/100 respectively, which were obviously better than those of the control group(P < 0.05) with no obvious side-effect. SXM is an effective and safe drug for aplastic anemia. Its mechanism might be likely due to Its regulating the immune function, which facilitates the recovery for the bone marrow hematopoiesis function.